Literature DB >> 23160090

Hydroxysafflor yellow a inhibits lipopolysaccharide-induced inflammatory signal transduction in human alveolar epithelial A549 cells.

Lijuan Song1, Yu Zhu, Ming Jin, Baoxia Zang.   

Abstract

Hydroxysafflor yellow A (HSYA) is an active ingredient obtained from the flower of Carthamus tinctorius L. The present study investigated the effects of HSYA on lipopolysaccharide (LPS)-induced inflammatory signal transduction in human alveolar epithelial A549 cells. A549 cells stimulated with LPS were incubated with three doses of HSYA (1, 4 and 16μmol/L). HSYA suppressed the expression of TLR-4, Myd88, ICAM-1, TNFα, IL-1β and IL-6 at the mRNA and protein level, and inhibited the adhesion of leukocytes to A549 cells. HSYA treatment also decreased NF-κB p65 nuclear translocation and inhibited the phosphorylation of p38 mitogen-activated protein kinase (p38 MAPK). These findings suggest that HSYA effectively inhibits LPS-induced inflammatory signal transduction in A549 cells. Crown
Copyright © 2012. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23160090     DOI: 10.1016/j.fitote.2012.11.004

Source DB:  PubMed          Journal:  Fitoterapia        ISSN: 0367-326X            Impact factor:   2.882


  15 in total

1.  Hydroxysafflor yellow A inhibits lipopolysaccharide-induced proliferation and migration of vascular smooth muscle cells via Toll-like receptor-4 pathway.

Authors:  Guoshuai Yang; Xiaoyan Zhou; Tao Chen; Yidong Deng; Dan Yu; Suyue Pan; Yanmin Song
Journal:  Int J Clin Exp Med       Date:  2015-04-15

2.  Safflower Yellow regulates microglial polarization and inhibits inflammatory response in LPS-stimulated Bv2 cells.

Authors:  Xing-Wang Yang; Yan-Hua Li; Hui Zhang; Yong-Fei Zhao; Zhi-Bin Ding; Jie-Zhong Yu; Chun-Yun Liu; Jian-Chun Liu; Wei-Jia Jiang; Qian-Jin Feng; Bao-Guo Xiao; Cun-Gen Ma
Journal:  Int J Immunopathol Pharmacol       Date:  2015-12-03       Impact factor: 3.219

3.  Xuebijing injection for acute organophosphorus pesticide poisoning: a systematic review and meta-analysis.

Authors:  Po Huang; Bo Li; Shuo Feng; Yuhong Guo; Guozhen Zhao; Dongdong Wang; Qingquan Liu
Journal:  Ann Transl Med       Date:  2019-03

4.  Traditional chinese medicine Xuebijing treatment is associated with decreased mortality risk of patients with moderate paraquat poisoning.

Authors:  Ping Gong; Zhidan Lu; Jing Xing; Na Wang; Yu Zhang
Journal:  PLoS One       Date:  2015-04-29       Impact factor: 3.240

5.  The Mechanism by Which Safflower Yellow Decreases Body Fat Mass and Improves Insulin Sensitivity in HFD-Induced Obese Mice.

Authors:  Huijuan Zhu; Xiangqing Wang; Hui Pan; Yufei Dai; Naishi Li; Linjie Wang; Hongbo Yang; Fengying Gong
Journal:  Front Pharmacol       Date:  2016-05-23       Impact factor: 5.810

6.  Hydroxysafflor yellow A attenuates the expression of inflammatory cytokines in acute soft tissue injury.

Authors:  Fang Dong; Changjiang Xue; Yu Wang; Yuanyuan Peng; Yadan Zhang; Ming Jin; Baoxia Zang
Journal:  Sci Rep       Date:  2017-01-11       Impact factor: 4.379

7.  Mechanism of enhanced oral absorption of hydrophilic drug incorporated in hydrophobic nanoparticles.

Authors:  Liang-Zhong Lv; Chen-Qi Tong; Jia Yu; Min Han; Jian-Qing Gao
Journal:  Int J Nanomedicine       Date:  2013-07-29

Review 8.  Anti-Inflammation of Natural Components from Medicinal Plants at Low Concentrations in Brain via Inhibiting Neutrophil Infiltration after Stroke.

Authors:  Jiannan Chen; Xiangjian Zhang; Cong Zhang; Wenhui Wang; Rong Chen; Honglei Jiao; Linlin Li; Lan Zhang; Lili Cui
Journal:  Mediators Inflamm       Date:  2016-09-05       Impact factor: 4.711

9.  Rosiglitazone Reduces Apoptosis and Inflammation in Lipopolysaccharide-Induced Human Umbilical Vein Endothelial Cells.

Authors:  Xiao-Xia Ji; Xiao-Jing Ji; Qian-Qian Li; Xiao-Xian Lu; Liang Luo
Journal:  Med Sci Monit       Date:  2018-09-06

Review 10.  Hydroxysafflor Yellow A: A Promising Therapeutic Agent for a Broad Spectrum of Diseases.

Authors:  Hui Ao; Wuwen Feng; Cheng Peng
Journal:  Evid Based Complement Alternat Med       Date:  2018-09-25       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.